Step into the intersection of translation and impact.
The School of Biological Sciences Bridging Biomedical Breakthroughs Summit convenes biannually to bring leaders across industry, academia, and innovation together, driving what’s next in science and exploring how bold ideas accelerate from the lab to real-world application.
The 4th Bridging Biomedical Breakthroughs Summit
AI in Biomedical Innovation: Accelerating Therapeutics, Diagnostics, and Imaging
Sponsored by Avalon BioVentures, Mintz, and Greenberg Traurig, LLP
Hosted by School of Biological Sciences in partnership with Office of Innovation and Commercialization and School of Medicine
Price Center West, Ballroom AB
- 12:00-1:00 p.m.: Check-in and networking with beverages available
- 1:00-5:30 p.m.: Main program
- 5:30-7:00 p.m.: Networking reception with beverages and heavy hors d'oeuvres
Explore our exciting lineup of powerhouse speakers and full agenda below!
Open to industry leaders, investors, entrepreneurs, legal experts, and academic researchers, including faculty, postdocs, graduate students, and undergraduates.
Join us to spark collaboration and the next breakthroughs in AI-driven biomedical innovation.
Our Most Dynamic Summit Yet: What's in Store
Experience an exciting new chapter of the Bridging Biomedical Breakthroughs Summit! Our Fall 2026 Summit features expanded programming, new segments, and multiple integrated networking opportunities in a larger venue designed to foster connections and collaboration. Join us for a special announcement from Dean Kit Pogliano and explore what's next in AI-driven biomedical innovation.
Expert Panels: From Discovery to Impact
Engage with leaders in biotechnology, healthcare, venture capital, and entrepreneurship across three dynamic panels exploring clinical adoption, pathways for advancing biomedical discoveries, and emerging innovators building the next generation of biotech ventures. Gain insights into translating research into real-world solutions, navigating strategic partnerships, and accelerating biomedical innovation through AI.
Innovation Pitches: AI-Enabled Biomedical Breakthroughs
Discover five groundbreaking research innovations emerging from UC San Diego, showcasing AI-enabled approaches to therapeutics, diagnostics, and imaging. Explore advances in kidney injury detection, malaria prevention, personalized Parkinson’s treatment, cancer diagnostics, and breast cancer risk assessment. Hear directly from researchers developing promising technologies with the potential to transform patient care.
Networking: Connect Across the Innovation Ecosystem
Connect with researchers, clinicians, biotechnology executives, entrepreneurs, investors, and industry leaders from across UC San Diego and the broader San Diego innovation ecosystem. Build meaningful relationships, explore potential collaborations, and discover opportunities to advance biomedical innovation through dedicated networking sessions and an evening reception featuring heavy hors d’oeuvres and beverages.
The Innovation Lineup: Fall 2026 Agenda & Speakers
12:00–1:00 p.m. | Check-in and Open Networking
Ballroom B — Coffee, lemonade, and water available
1:00–1:15 p.m. | Welcome & AI in Biomedical Innovations at UC San Diego
Opening remarks will feature a special announcement from Dean Kit Pogliano and insights into how artificial intelligence is transforming biomedical research, healthcare, and patient care through groundbreaking discoveries, interdisciplinary collaboration, and emerging innovations across UC San Diego.

Kit Pogliano, PhD
Dean, School of Biological Sciences
Distinguished Professor, Department of Molecular Biology
Richard C. Atkinson Endowed Chair, UC San Diego
Special Advisor to Chancellor Pradeep Khosla, UC San Diego
Dr. Pogliano is a pioneering microbiologist whose discoveries helped establish modern bacterial cell biology. A fellow of two leading scientific academies, she co-founded Linnaeus Bioscience and co-invented technologies advancing antibiotic discovery. An influential advocate for scientific entrepreneurship, she champions interdisciplinary research, strategic partnerships, and translating breakthrough discoveries into societal impact.

Amy Sitapati, M.D.
Clinical Professor, School of Medicine
Lawrence S. Friedman Professor of Population Health, Endowed Chair
Executive Director, Institute for Applied Health Intelligence
Chief Medical Information Officer, Population Health
Co-Principal Investigator, California Integrated Vital Records System
Site Principal Investigator, UC San Diego NIH All of Us
Primary Care Internist, Division of General Internal Medicine
Dr. Sitapati is a nationally recognized physician and clinical informatics leader advancing artificial intelligence, digital health, and population health analytics. She co-chairs UC San Diego’s Artificial Intelligence Committee, serves as site principal investigator for the NIH All of Us Research Program, and received the Leonard Tow Humanism in Medicine Award.
1:15–2:00 p.m. | From Breakthrough to Buy-In: Would You Use It?
This panel will explore what it takes for emerging biomedical technologies to achieve clinical adoption, from identifying unmet needs and demonstrating clinical value to navigating validation, implementation, and the decisions that bring innovations into patient care.

Maya Gosztyla, PhD (moderator)
Co-Founder and Chief Scientific Officer, BrainStorm Therapeutics, Inc.
Dr. Gosztyla leads research at BrainStorm Therapeutics, developing drugs for neurological diseases using patient-derived brain organoids and AI models. She earned her PhD at UC San Diego as an NSF Graduate Research Fellow. Her honors include Biocom’s Life Science Catalyst Award, Ohio State’s William Oxley Thompson Award, and BIO’s Start-Up Stadium.

Shimul Chowdhury, PhD
Vice President of Laboratory Operations, ClearNote Health
Dr. Chowdhury is a board-certified molecular geneticist and licensed clinical laboratory director who has held leadership positions at Rady Children's Institute for Genomic Medicine, Illumina, and Quest Diagnostics. His expertise spans clinical genomics, molecular diagnostics, laboratory operations, and the implementation of advanced genetic testing technologies in patient care.

Deborah Nguyen, PhD
Operating Partner, Red Tree Venture Labs
Dr. Nguyen brings more than 20 years of pharmaceutical and biotechnology leadership spanning drug discovery, therapeutic development, and venture-backed company building. She previously held senior research positions at GNF/Novartis, Organovo, COI Pharmaceuticals, and Takeda, where she helped advance immunology programs and acquisitions of clinical-stage therapeutic assets.

Mark Schultzel, M.D., MBA
Chair, Department of Orthopaedic Surgery, United Medical Doctors
Chief, Department of Orthopaedic Surgery, Sharp Community Medical Group
Chief Medical Officer, Modiv Health
Dr. Schultzel is a board-certified orthopaedic surgeon and nationally recognized shoulder and elbow specialist. Named among Becker’s Healthcare’s 15 Orthopedic Surgeons to Know in 2026, he is a triple alumnus of UC San Diego, professional and Olympic-level team physician, and an advocate for advanced surgical technologies and digital health innovation.
2:00–2:45 p.m. | From Discovery to Impact: Innovation Pathways for AI-Enabled Biomedical Innovation
Explore how promising biomedical discoveries move from the laboratory to the marketplace through strategic partnerships, investment, and innovation pathways, with insights from a panel of leaders in biotechnology, venture capital, and intellectual property.

Magda Marquet, PhD (moderator)
Co-Founder, ALMA Life Sciences
Dr. Marquet is a serial biotechnology entrepreneur who co-founded Althea Technologies, guiding its successful acquisition by Ajinomoto. An Ernst & Young Entrepreneur of the Year and CONNECT Entrepreneur Hall of Fame inductee, she has served on the boards of Arcturus Therapeutics, AnaptysBio, and numerous life sciences organizations.

Jill Mooney, PhD
Chief Scientific Officer, Tregsherpa
Chief Development Officer, Korsa Therapeutics
Advisor, AvalonBioVentures
Dr. Mooney brings 20 years of expertise advancing biologics and cell and gene therapies. Formerly Senior Vice President of R&D at ElevateBio and Head of R&D at Synthorx, she helped advance two therapeutic programs from discovery to first-in-human trials in under three years and contributed to five patent applications.

Eva Wang, PhD, MBA
Venture Partner, MedTech Innovation Hub
Investor, NuFund Venture Group
Dr. Wang is a biotechnology executive and investor with over two decades of experience in AI, multi-omics, and biotech commercialization. She has held senior leadership roles, contributing to multiple IPOs and acquisitions, and developed AI-enabled diagnostics, including Veracyte’s Afirma genomic classifier. She supports scientists and founders in translating discoveries into fundable companies.

John Wehrli, PhD
Senior Partner, Greenberg Traurig, LLP
Advisor, Lionheart Ventures
Dr. Wehrli is a biotechnology attorney, venture capital advisor, and computational neuroscientist with more than four decades of industry experience. Named Best Lawyers’ 2022 Lawyer of the Year in Biotechnology and Life Sciences, he has advised on approximately $135 billion in transactions spanning biotechnology, pharmaceuticals, artificial intelligence, and neurotechnology.
2:45–3:15 | Innovation Pitches #1-2
Hear UC San Diego researchers pitch their emerging AI-driven innovations in therapeutics, diagnostics, and imaging, showcasing promising discoveries with the potential to address unmet medical needs, advance patient care, and create new opportunities for real-world impact.

Introductions by Rachel Dutton, PhD
Executive Director of Innovation, School of Biological Sciences, UC San Diego
Dr. Dutton pioneered the use of fermented foods as models for understanding complex microbial communities. A Packard Fellow, Pew Scholar, and NIH Director's New Innovator Award recipient, she has also advanced scientific discovery and commercialization through leadership roles at Arcadia Science and the Astera Institute.
Innovation Pitch 1: AI-Powered Kidney Injury Detection

Linda Awdishu, PharmD
Professor of Clinical Pharmacy Practice and Sciences and Chair, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego
Dr. Awdishu is a Fellow of the American Society of Nephrology whose research has advanced understanding of drug-induced kidney injury, pharmacogenomics, and medication safety. She established multidisciplinary kidney care programs and clinical pharmacy services and has received numerous honors for excellence in clinical practice, teaching, mentorship, and academic leadership.
Innovation Pitch 2: AI-Designed Malaria Prevention

Adrian Jinich, PhD
Assistant Professor, Department of Biochemistry and Molecular Biophysics, School of Physical Sciences, and Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego
Dr. Jinich is a Howard Hughes Medical Institute Hanna Gray Fellow recognized among Cell Press’s 100 most inspiring Hispanic/Latinx scientists. His research combines AI, machine learning, and biochemistry to discover enzyme functions and develop novel approaches to treating tuberculosis and malaria. He also co-founded Clubes de Ciencia México, expanding STEM education.
3:15–3:35 | Networking Break
Ballroom B — Coffee, lemonade, and water available
3:35–4:20 | Innovation Pitches #3-5
Innovation Pitch 3: Personalized Parkinson's Disease Treatment

Byungkook Lim, PhD
Professor, Department of Neurobiology, School of Biological Sciences, UC San Diego
Dr. Lim is a neuroscientist whose research has advanced understanding of the neural circuits governing reward, motivation, and movement. Previously a postdoctoral researcher at Stanford University, he has conducted influential studies identifying distinct brain circuits underlying reward and aversion. His laboratory investigates neural mechanisms implicated in Parkinson’s disease, addiction, and depression.
Innovation Pitch 4: AI-Enabled Cancer Diagnostics

Shuvro P. Nandi, PhD
Assistant Project Scientist, Alexandrov Laboratory, Department of Cellular and Molecular Medicine, School of Medicine, UC San Diego
Dr. Nandi is a cancer genomics researcher specializing in DNA repair, mutational signatures, and ultra-rare mutation detection. He developed an advanced error-corrected sequencing approach capable of detecting exceptionally rare mutations and has contributed to research published in Nature, Nature Cancer, PNAS, and JAMA Oncology.
Innovation Pitch 5: AI-Enhanced Breast Cancer Risk Assessment (joint presentation)

Rebecca Rakow-Penner, M.D., PhD
Associate Professor, Department of Radiology
Affiliate Professor, Department of Bioengineering
Adjunct Professor, Departments of Obstetrics, Gynecology and Reproductive Sciences, and Radiation Medicine
UC San Diego
Dr. Rakow-Penner is a physician-scientist advancing magnetic resonance imaging for breast and gynecologic diseases. She is NIH funded and recognized as a 2026 Distinguished Investigator by the Academy for Radiology & Biomedical Imaging Research. She earned her MD/PhD at Stanford, bioengineering master’s from Caltech, and undergraduate engineering degree from Harvard.

Jingjing Zou, PhD
Associate Professor in Residence, Herbert Wertheim School of Public Health and Human Longevity Science, UC San Diego
Dr. Zou is a biostatistician and AI researcher advancing multimodal machine learning, medical imaging, and wearable health technologies. An NIH-funded principal investigator with a PhD in Statistics from Columbia University, she develops computational methods supporting cancer imaging, digital health measurement, and the study of physical activity and healthy aging.
4:20–4:30 | Nucleate and RAIN: Building the Future of Biomedical Innovators
Hear from emerging leaders at Nucleate San Diego and the Real World AI Network (RAIN) as they highlight opportunities for UC San Diego researchers and students to connect with industry, develop entrepreneurial skills, and transform scientific discoveries and AI-driven innovations into real-world ventures.

Introductions by Sara Werner, PhD
Executive Director of Strategic Programs, School of Biological Sciences, UC San Diego
Dr. Werner is a scientific and strategic partnerships leader with more than two decades of experience spanning industry research, strategic alliances, and academic innovation. Previously Associate Director of Program and Alliance Management at Senomyx, she held progressive scientific leadership positions and now directs strategic initiatives advancing research and innovation at UC San Diego.
Nucleate: Supporting the Next Generation of Biotech Entrepreneurs
Nucleate San Diego will highlight how it supports emerging biotech entrepreneurs in translating research into startups, and sharing opportunities for UC San Diego researchers and students to get involved.

Dhruv Khanduja
PhD Student, UC San Diego
Co-Managing Director, Nucleate San Diego
Dhruv is a third-year PhD student studying CD8 T cell responses to infection in Ananda Goldrath’s laboratory. Previously at Yale, he studied molecular mechanisms of B-cell lymphoma and served as Yale Postgraduate Association President. Through Nucleate San Diego, he supports emerging biotechnology ventures and scientific entrepreneurship.

Gabriel Ong
PhD Student, Scripps Research
Co-Managing Director, Nucleate San Diego
Gabriel is a second-year PhD student and A*STAR National Science Scholar whose research applies artificial intelligence to protein engineering and biotechnology. He develops computational models for designing proteins with non-canonical amino acids, expanding possibilities for protein engineering. His previous machine learning research was published in ACS Synthetic Biology and Scientific Reports.
The Real World AI Network (RAIN): Connecting AI Research, Industry, and Entrepreneurship
RAIN will highlight its mission, its role in connecting AI research with industry and entrepreneurship, and opportunities for emerging researchers and entrepreneurs to get involved.

Pranav Soma
Co-Founder and President, RAIN
Pranav is a computer scientist and entrepreneur who co-founded UC San Diego’s Real World AI Network (RAIN), connecting students with leading researchers, industry innovators, and entrepreneurial opportunities. A graduate student in computer science, he brings experience in artificial intelligence, robotics, software engineering, and interdisciplinary technology development.

Aryan Pershad
Co-Founder and Incoming President, RAIN
Co-Founder and CEO, Stele
Aryan is a UC San Diego bioinformatics student and entrepreneur advancing AI-driven health technology. As co-founder and CEO of Stele, he develops wearable health technologies. He also leads entrepreneurial initiatives as co-founder of UC San Diego’s Real World AI Network (RAIN) and Founders Network, connecting emerging founders with collaborators, industry partners, and opportunities.
4:30–5:15 | Panel 3: Next-Generation Innovators: Building What's Next
Hear from emerging UC San Diego researchers and entrepreneurs as they share their journeys translating scientific discoveries into promising biomedical ventures, including the challenges, opportunities, and lessons learned in bringing innovations from the laboratory to the marketplace.

Chelsea Hewitt (moderator)
Senior Director, Regional Engagement & Incubation, Johnson & Johnson
Chelsea was a founding member of Johnson & Johnson's JLABS, helping establish its global biotechnology incubation network. Her career spans technology investing, venture incubation, strategic partnerships, and business development. She connects emerging life sciences companies with researchers, investors, corporate resources, and commercialization opportunities while strengthening San Diego's regional innovation ecosystem.

Kiran Kumar
Founder & CEO, Timeless Biotech
Kiran is a UC San Diego-trained bioengineer advancing healthcare through AI-driven innovation. Timeless launched MenoTime, the first ovarian age clock and menopause timing predictor. Featured in USA Today and Business Insider, she was recognized among Women of Wearables' 100 Trailblazing Leaders in Menopause and the prestigious Nestlé–Tufts Women's Health Challenge.

Carter Palmer, PhD
Co-Founder & CEO, Third Element Bio
Dr. Palmer is a neuroscientist and entrepreneur developing AI-designed RNA therapies targeting the drivers of brain aging and neurodegenerative diseases. Named UC San Diego’s 2026 Student/Alumni Innovator of the Year, he co-founded Third Element Bio, an NIH-funded startup recognized as a 2026 Connect Cool Company and Otsuka/BioLabs Golden Ticket recipient.

Joseph Solvason, PhD
Co-Founder & CEO, Gaius Therapeutics
Dr. Solvason has spent a decade decoding how regulatory DNA tunes gene expression, with co-first-author Nature and Nature Genetics papers. Now CEO of Gaius Therapeutics, he uses AI to engineer transcriptional enhancers for in vivo CAR-Tregs targeting autoimmune disease. He received Nucleate and Genentech’s Biology Explorers Award, selected from 800 applicants.
5:15–5:30 | Innovation Pathways at UC San Diego and Next Steps
Discover UC San Diego's innovation pathways, resources, and initiatives supporting researchers and entrepreneurs in translating discoveries into real-world impact. This closing session will highlight opportunities for industry partnerships, entrepreneurial development, and continued collaboration beyond the Summit.

Paul Roben, PhD
Associate Vice Chancellor, Innovation and Commercialization, UC San Diego
Associate Vice Chancellor Roben leads UC San Diego’s innovation and commercialization enterprise, integrating technology transfer, intellectual property, industry partnerships, and entrepreneurial development. Previously a senior technology development leader at the Salk Institute and Director of Biotechnology for Enterprise Ireland, he has extensive experience building biotechnology companies and translating discoveries into commercial opportunities.

Melissa Hoon
Director, Corporate Relations and Professional Development, School of Biological Sciences, UC San Diego
Melissa brings 15 years of higher education experience building strategic partnerships and programs connecting academia, industry, and innovation. She spearheaded the Bridging Biomedical Breakthroughs Summit and BioSci Innovation Pitch, and leads initiatives spanning corporate partnerships, entrepreneurship, and experiential learning to strengthen pathways from scientific discovery to real-world impact.
5:30–7:00 p.m. | Networking Reception
Ballroom B — Beverages and heavy hors d'oeuvres
Let's Connect
Have questions about the Summit or interested in getting involved? We'd love to hear from you. Reach out to learn more about the program, explore opportunities for collaboration or sponsorship, and connect with the School of Biological Sciences innovation team.